Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 22% ± 6% | |
epithelial cell | 6 studies | 29% ± 12% | |
basal cell | 5 studies | 27% ± 10% | |
ciliated cell | 5 studies | 28% ± 8% | |
oligodendrocyte | 5 studies | 24% ± 5% | |
macrophage | 4 studies | 20% ± 4% | |
astrocyte | 4 studies | 25% ± 4% | |
oligodendrocyte precursor cell | 4 studies | 29% ± 9% | |
GABAergic neuron | 3 studies | 36% ± 3% | |
glutamatergic neuron | 3 studies | 39% ± 5% | |
microglial cell | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 19% ± 2% | |
neuron | 3 studies | 26% ± 7% | |
plasmacytoid dendritic cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 458.58 | 180 / 180 | 100% | 5.17 | 430 / 430 |
esophagus | 100% | 378.79 | 1444 / 1445 | 100% | 4.57 | 183 / 183 |
lung | 100% | 491.68 | 578 / 578 | 100% | 5.70 | 1154 / 1155 |
brain | 100% | 389.97 | 2641 / 2642 | 100% | 6.18 | 704 / 705 |
stomach | 100% | 381.06 | 359 / 359 | 100% | 5.44 | 285 / 286 |
breast | 100% | 466.45 | 459 / 459 | 100% | 5.11 | 1114 / 1118 |
bladder | 100% | 457.19 | 21 / 21 | 99% | 5.60 | 498 / 504 |
intestine | 100% | 425.49 | 966 / 966 | 99% | 5.57 | 520 / 527 |
prostate | 100% | 391.40 | 245 / 245 | 99% | 4.59 | 495 / 502 |
pancreas | 100% | 389.63 | 327 / 328 | 99% | 3.97 | 176 / 178 |
skin | 100% | 565.48 | 1808 / 1809 | 98% | 4.94 | 462 / 472 |
uterus | 100% | 381.78 | 170 / 170 | 98% | 4.53 | 448 / 459 |
thymus | 100% | 550.30 | 653 / 653 | 97% | 4.33 | 589 / 605 |
kidney | 100% | 473.27 | 89 / 89 | 96% | 3.69 | 868 / 901 |
liver | 100% | 240.50 | 226 / 226 | 94% | 2.58 | 381 / 406 |
adrenal gland | 100% | 883.54 | 258 / 258 | 90% | 3.51 | 208 / 230 |
adipose | 100% | 466.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.60 | 29 / 29 |
spleen | 100% | 490.63 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.92 | 1 / 1 |
muscle | 99% | 302.40 | 798 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 306.96 | 1322 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 3.01 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 3.57 | 78 / 80 |
heart | 97% | 283.39 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 288.84 | 661 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006506 | Biological process | GPI anchor biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0051377 | Molecular function | mannose-ethanolamine phosphotransferase activity |
GO_0004307 | Molecular function | ethanolaminephosphotransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PIGF |
Protein name | Phosphatidylinositol glycan anchor biosynthesis class F PIGF protein (Phosphatidylinositol glycan, class F, isoform CRA_c) Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F) (GPI11 homolog) |
Synonyms | hCG_1987697 |
Description | FUNCTION: Involved in GPI-anchor biosynthesis . It acts through the transfer of ethanolamine phosphate to the third mannose of GPI. . |
Accessions | ENST00000281382.11 [Q07326-1] E5RIN5 ENST00000420164.5 ENST00000474980.1 F8WEN5 Q6IB04 ENST00000306465.8 [Q07326-2] ENST00000412717.1 H7C392 Q07326 |